Latest Rosuvastatin Stories
CrestorCardiomyopathyLawyer.com aims to provide information about the possible risks of Crestor®.
MORRISTOWN, N.J., Aug. 10, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received tentative approval from the United States Food and Drug Administration (FDA) for its rosuvastatin zinc 5, 10, 20 and 40 mg tablets.
EDISON, N.J., July 15, 2011 /PRNewswire/ -- Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase.
LONDON, June 28, 2011 /PRNewswire/ -- Rheumatoid arthritis treatment Humira will assume Lipitor's crown as the world's biggest selling drug, while Pfizer will cling on to its ranking as the biggest seller of prescription medicines through to 2016, according to the World Preview 2016 (second edition) report published today by EvaluatePharma, the premier provider of pharma and biotech analysis. Lipitor's patent expiry this year precipitates the steepest decline in the...
FLORHAM PARK, N.J., April 7, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S.
A new National Cancer Institute (NCI) sponsored study being launched this week at Pittsburgh's Allegheny General Hospital (AGH) will evaluate the cholesterol lowering drug Rosuvastatin (Crestor) for its potential to reduce the risk of colon cancer. Pittsburgh, PA (Vocus/PRWEB) March 31, 2011 A new National Cancer Institute (NCI) sponsored study being launched this week at Allegheny General Hospital (AGH) will evaluate the cholesterol lowering drug Rosuvastatin (Crestor) for its potential...
WILMINGTON, Del., March 24, 2011 /PRNewswire-USNewswire/ -- Christiana Care Health System's Helen F.
New Partnership Kicks Off During National Nutrition Month, Bringing Simple, Low-Cholesterol Recipes Directly to Your Kitchen Wilmington, DE (PRWEB) March 15, 2011 AstraZeneca (NYSE:AZN) today announced the launch of a partnership with Food Universityâ„¢ â€” a culinary education and entertainment platform â€” to educate people about the importance of maintaining a healthy diet as one way to help manage cholesterol.
WILMINGTON, Del., March 14, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the launch of a partnership with Food University(TM) -- a culinary education and entertainment platform -- to educate people about the importance of maintaining a healthy diet as one way to help manage cholesterol.
- A woman chauffeur.
- A woman who operates an automobile.